Closed-end funds have seen significant discount narrowing in 2024 across the board, as discounts have been cut in more than half on average. Despite record highs being hit regularly this year in the S&P 500, NASDAQ 100, and DJIA, opportunities still exist as not everything has been participating on the upside equally. Investors could consider funds like the BME and FLC, which may still offer at...
Not many people know this, but if you really want to diversify—deftly balancing and rebalancing to maximize (and protect) your gains, you need to invest in closed-end funds (CEFs).
Last time around, we had rated BlackRock Health Sciences Trust as a hold. The fund has not delivered much since then, but the sector has gotten really oversold. We go over the thesis for this one today and tell you why we think its is a Buy.
This month, I've added to 11 different positions, but most of these were related to repurchases after the BlackRock tender offers. While I added to 11 different positions, these were all positions I had already held previously, so there were no new positions this month. In fact, I sold out of a fund to consolidate my holdings and reduce the number of funds held, as I did last month as well.
BlackRock Health Sciences Trust offers exposure to healthcare companies and employs a covered call strategy to generate option premiums to help support the distribution. The latest tender offer measurement period for BlackRock discount management programs has come to a close, and BME made the list, but it was close this time. The fund's 6.15% distribution yield might not be the most exciting, b...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.